These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 22821812)

  • 41. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.
    Kitadai Y; Sasaki T; Kuwai T; Nakamura T; Bucana CD; Hamilton SR; Fidler IJ
    Int J Cancer; 2006 Dec; 119(11):2567-74. PubMed ID: 16988946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
    NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
    J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.
    Rosenberg A; Mathew P
    Expert Opin Investig Drugs; 2013 Jun; 22(6):787-94. PubMed ID: 23540855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
    Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy.
    Wang Y; Mandal D; Wang S; Kleinerman ES; Pollock RE; Lev D; Hayes-Jordan A
    Cancer; 2010 Aug; 116(16):3892-902. PubMed ID: 20564078
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth in vitro and in vivo.
    Ahn JO; Coh YR; Lee HW; Shin IS; Kang SK; Youn HY
    Anticancer Res; 2015 Jan; 35(1):159-68. PubMed ID: 25550547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation.
    Stahtea XN; Roussidis AE; Kanakis I; Tzanakakis GN; Chalkiadakis G; Mavroudis D; Kletsas D; Karamanos NK
    Int J Cancer; 2007 Dec; 121(12):2808-14. PubMed ID: 17721919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.
    Yokoi K; Sasaki T; Bucana CD; Fan D; Baker CH; Kitadai Y; Kuwai T; Abbruzzese JL; Fidler IJ
    Cancer Res; 2005 Nov; 65(22):10371-80. PubMed ID: 16288027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation increases invasion of gene-modified mesenchymal stem cells into tumors.
    Zielske SP; Livant DL; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):843-53. PubMed ID: 18849123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma.
    Apte SM; Fan D; Killion JJ; Fidler IJ
    Clin Cancer Res; 2004 Feb; 10(3):897-908. PubMed ID: 14871965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.
    Fontanella R; Pelagalli A; Nardelli A; D'Alterio C; Ieranò C; Cerchia L; Lucarelli E; Scala S; Zannetti A
    Cancer Lett; 2016 Jan; 370(1):100-7. PubMed ID: 26517945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model.
    Sartoris S; Mazzocco M; Tinelli M; Martini M; Mosna F; Lisi V; Indraccolo S; Moserle L; Cestari T; Riviera AP; Bifari F; Tridente G; Pizzolo G; Krampera M
    Stem Cells Dev; 2011 Apr; 20(4):709-19. PubMed ID: 20695752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation.
    Vlahovic G; Rabbani ZN; Herndon JE; Dewhirst MW; Vujaskovic Z
    Br J Cancer; 2006 Oct; 95(8):1013-9. PubMed ID: 17003785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.
    Zhu W; Xu W; Jiang R; Qian H; Chen M; Hu J; Cao W; Han C; Chen Y
    Exp Mol Pathol; 2006 Jun; 80(3):267-74. PubMed ID: 16214129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
    Holdhoff M; Kreuzer KA; Appelt C; Scholz R; Na IK; Hildebrandt B; Riess H; Jordan A; Schmidt CA; Van Etten RA; Dörken B; le Coutre P
    Blood Cells Mol Dis; 2005; 34(2):181-5. PubMed ID: 15727903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression.
    De Boeck A; Hendrix A; Maynard D; Van Bockstal M; Daniëls A; Pauwels P; Gespach C; Bracke M; De Wever O
    Proteomics; 2013 Jan; 13(2):379-88. PubMed ID: 23175172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3.
    Schmohl KA; Müller AM; Wechselberger A; Rühland S; Salb N; Schwenk N; Heuer H; Carlsen J; Göke B; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2015 Dec; 22(6):941-52. PubMed ID: 26307023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.
    Vittal R; Zhang H; Han MK; Moore BB; Horowitz JC; Thannickal VJ
    J Pharmacol Exp Ther; 2007 Apr; 321(1):35-44. PubMed ID: 17218487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
    Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
    [No Abstract]   [Full Text] [Related]  

  • 60. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice.
    Huang WH; Chang MC; Tsai KS; Hung MC; Chen HL; Hung SC
    Oncogene; 2013 Sep; 32(37):4343-54. PubMed ID: 23085755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.